DeepSight™ Technology, Inc. Market Research Report

Company Overview

• Name: DeepSight™ Technology, Inc.

• Mission: To revolutionize medical imaging by delivering a quantum leap in performance in ultrasound imaging and broadening its applications.

• Foundation: Founded in 2019 by Nader Sadrzadeh, Lan Yang, and Anand Chandrasekher.

• Key People:

• Nader Sadrzadeh, Co-Founder & CEO

• Dr. Lan Yang, PhD, Co-Founder & CTO

• Dr. John Chong, PhD, Chief Operating Officer

• Dr. Diku Mandavia, M.D., Chief Medical Officer

• Anand Chandrasekher, Co-Founder & Board Member

• Headquarters: San Francisco Bay Area, California, and Clayton, Missouri.

• Number of Employees: No information is available.

• Revenue: No information is available.

• What is the Company Known For: Known for its innovative advancements in ultrasound imaging, particularly with their proprietary NeedleVue™ Technology.

Products

1. DeepSight™ Technology Solutions

• Description: Incorporates proprietary hardware, software, and advanced technologies intended to improve the image quality and extend depth penetration of medical ultrasound.

• Key Features:

• Enhances diagnostic imaging with higher signal to noise ratio, greater angle of reception, and larger bandwidth.

• Designed to provide cost-effective and accessible imaging solutions in various environments – urban, rural, and remote.

2. NeedleVue™ Technology

• Description: A revolutionary advancement in ultrasound-assisted needle guidance technology.

• Key Features:

• Exceptional Precision: Facilitates confident results by reducing guesswork in ultrasound-guided procedures.

• Versatility: Multidirectional technologies enhance maneuverability.

• OnPoint™ Imaging: Intended to generate high-resolution imaging from the needle tip's point-of-view.

• CEUS Compatibility: Operates effectively with contrast agents present.

Recent Developments

• Products Launched:

• NeedleVue™ Solution: Announced in November 2023, this product revolutionizes ultrasound-guided tool guidance with state-of-the-art functionality.

• NeedleVue™ LiteCart System: Set to be showcased at RSNA 2024 as a pioneering solution for ultrasound-guided interventional procedures.

• New Features:

• NeedleVue technology includes high-resolution imaging and CEUS compatibility aiming to facilitate more precise interventions.

• Partnerships and Collaborations:

• DeepSight is open to development partnerships and technology licensing to enhance existing products.

• Key Appointments:

• Dr. Diku Mandavia appointed as Chief Medical Officer in January 2025, emphasizing the company's commitment to medical leadership and expertise.

This report provides a concise but thorough view of DeepSight™ Technology's offerings, recent innovations, and key developments within the company, designed to establish them as a leader in advancing medical ultrasound technology.